Serina Therapeutics (SER) Current Assets (2017 - 2026)

Serina Therapeutics has disclosed Current Assets across 10 years of filings, most recently posting $25.0 million for Q2 2026.

• In Q2 2026, Current Assets rose 213.23% year-over-year to $25.0 million; the TTM figure through Jun 2026 stood at $25.0 million (up 213.23% YoY), while the FY2025 annual figure was $6.1 million, up 7.12% from the prior year.
• Current Assets came in at $25.0 million for Q2 2026 at Serina Therapeutics, up from $6.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $25.0 million in Q2 2026 to a low of $1.1 million in Q3 2023.
• Average Current Assets over 5 years is $6.1 million, with a median of $5.7 million recorded in 2024.
• Year-over-year, Current Assets soared 560.52% in 2024 and tumbled 35.62% in 2025.
• Over 5 years, Current Assets stood at $2.5 million in 2022, then surged by 210.6% to $7.6 million in 2023, then retreated by 25.5% to $5.7 million in 2024, then grew by 7.12% to $6.1 million in 2025, then soared by 311.68% to $25.0 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $25.0 million in Q2 2026, $6.1 million in Q4 2025, and $11.5 million in Q3 2025.